Compare BBD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBD | IQV |
|---|---|---|
| Founded | 1943 | 1982 |
| Country | Brazil | United States |
| Employees | 80348 | 93000 |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 35.1B |
| IPO Year | N/A | 2013 |
| Metric | BBD | IQV |
|---|---|---|
| Price | $3.69 | $235.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $227.13 |
| AVG Volume (30 Days) | ★ 33.3M | 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.82% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $70.86 | $6.77 |
| Revenue Next Year | $8.33 | $5.89 |
| P/E Ratio | ★ $9.20 | $132.43 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $2.73 | $154.50 |
| 52 Week High | $4.30 | $247.05 |
| Indicator | BBD | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 78.92 |
| Support Level | $3.41 | $220.85 |
| Resistance Level | $3.74 | $245.60 |
| Average True Range (ATR) | 0.07 | 6.02 |
| MACD | 0.01 | 1.47 |
| Stochastic Oscillator | 81.22 | 97.45 |
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.